Stock listing
CUE Stock Price, News, Filings & Events — Cue Biopharma, Inc.
Selected listing: CUE · NASDAQ · USD · US
This page tracks Cue Biopharma, Inc.'s CUE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CUE:NASDAQ. CUE:NASDAQ is the stock-level entry point for investors researching Cue Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cue Biopharma, Inc. is a public company traded under the ticker CUE on the American market. The company has a market capitalization of approximately $130.88 million. Cue Biopharma focuses on developing innovative therapies for cancer and autoimmune diseases.
- Ticker
- CUE:NASDAQ
- Asset type
- Stock
- Market cap
- $269.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Cue Biopharma, Inc. CUE:NASDAQ stock context
This page tracks Cue Biopharma, Inc.'s CUE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CUE:NASDAQ. CUE:NASDAQ is the stock-level entry point for investors researching Cue Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cue Biopharma, Inc. is a public company traded under the ticker CUE on the American market. The company has a market capitalization of approximately $130.88 million. Cue Biopharma focuses on developing innovative therapies for cancer and autoimmune diseases.
Latest news from Cue Biopharma, Inc.
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
September 20, 2026
Currency Exchange International : Reports a 24% Increase in its Third Quarter Gro...
September 9, 2026
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
August 3, 2026
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
July 13, 2026
Cue Biopharma Announces $50.0 Million Private Placement
July 8, 2026
Cue Biopharma, Inc. earnings calls
Cue Biopharma, Inc. (CUE) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call
August 19, 2024 · Replay with transcript and chapters
Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call
April 8, 2024 · Replay with transcript and chapters
Cue Biopharma, Inc. (CUE) Q3 2023 Earnings Call
November 9, 2023 · Replay with transcript and chapters
Cue Biopharma, Inc. (CUE) Q2 2023 Earnings Call
August 9, 2023 · Replay with transcript and chapters
Cue Biopharma, Inc. (CUE) Q4 2022 Earnings Call
March 21, 2023 · Replay with transcript and chapters
Research Cue Biopharma, Inc.
Cue Biopharma, Inc. investor report
Review AI stock analysis and investor report context for CUE:NASDAQ.
Cue Biopharma, Inc. company profile
View the public company page for Cue Biopharma, Inc. on 6ix.
Cue Biopharma, Inc. news
Read company news and market updates connected to Cue Biopharma, Inc..
Cue Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Cue Biopharma, Inc..
Alternate listings
CUE:BOATS
US · USD
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
1UC0:GETTEX
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
A426PN:LSX
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
A426PN:LS
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
1UC0:TRADEGATE
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
1UC0:FWB
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
1UC0:DUS
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
1UC0:MUN
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.
1UC0:SWB
DE · EUR
Alternate listing for Cue Biopharma, Inc.; the primary context on this page is CUE:NASDAQ.